JMV-3042

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameJMV-3042
Drug Alias NameAceinnonapeptide targeting ACE (University of Montpellier)JMV-3042
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiotensin-converting enzyme modulators
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Montpellier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Montpellier
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A